Potential of metabolic engineering in bacterial nanosilver synthesis

Designer bacterial cell factories for improved production of commercially valuable non-ribosomal peptides

Non-ribosomal peptides have gained significant attention as secondary metabolites of high commercial importance. This group houses a diverse range of bioactive compounds, ranging from biosurfactants to antimicrobial and cytotoxic agents. However, low yield of synthesis by bacteria and excessive losses during purification hinders the industrial-scale production of non-ribosomal peptides, and subsequently limits their widespread applicability. While isolation of efficient producer strains and optimization of bioprocesses have been extensively used to enhance yield, further improvement can be made by optimization of the microbial strain using the tools and techniques of metabolic engineering, synthetic biology, systems biology, and adaptive laboratory evolution. These techniques, which directly target the genome of producer strains, aim to redirect carbon and nitrogen fluxes of the metabolic network towards the desired product, bypass the feedback inhibition and repression mechanisms that limit the maximum productivity of the strain, and even extend the substrate range of the cell for synthesis of the target product. The present review takes a comprehensive look into the biosynthesis of bacterial NRPs, how the same is regulated by the cell, and dives deep into the strategies that have been undertaken for enhancing the yield of NRPs, while also providing a perspective on other potential strategies that can allow for further yield improvement. Furthermore, this review provides the reader with a holistic perspective on the design of cellular factories of NRP production, starting from general techniques performed in the laboratory to the computational techniques that help a biochemical engineer model and subsequently strategize the architectural plan.

Advances in biogenically synthesized shaped metal- and carbon-based nanoarchitectures and their medicinal applications

Non-spherical metal-based and carbon-based nanostructures have found applications in every facet of scientific endeavors, including engineering and biomedical fields. These nanostructures attract attention because of their biocompatibility and negligible cytotoxicity. Chemical and physical methods have been used for synthesizing earlier generations of metal-based and carbon-based nanostructures with variable architectures, including nanorods, nanowires, nanodots and nanosheets. However, these synthesis strategies utilize organic passivators which are toxic to the environment and the human body. Biogenic synthesis of nanoparticles is becoming increasing popular because of the necessity to develop eco-friendly and non-toxic strategies. Nanoparticles synthesized by natural compounds have immense potential in the biomedical arena. The present review focuses on plant-mediated synthesis of metal-based and carbon-based non-spherical nanoarchitectures and the role of green synthesis in improving their activities for biomedical applications.